Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.15 - $6.01 $3.24 Million - $9.06 Million
-1,507,469 Reduced 99.24%
11,500 $25,000
Q1 2022

May 13, 2022

SELL
$2.8 - $6.21 $4.72 Million - $10.5 Million
-1,685,761 Reduced 52.6%
1,518,969 $5.64 Million
Q4 2021

Feb 14, 2022

BUY
$6.14 - $16.2 $19.7 Million - $51.9 Million
3,204,730 New
3,204,730 $19.7 Million

Others Institutions Holding LIAN

About LianBio


  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $32.5M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.